We are live on ! Find out more
AZN icon

AstraZeneca
AZN

331 hedge funds and large institutions have $5.84B invested in AstraZeneca in 2013 Q2 according to their latest regulatory filings, with 331 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

227% more call options, than puts

Call options by funds: $100M | Put options by funds: $30.6M

9.87% more ownership

Funds ownership: 0% → 9.87% (+9.9%)

Holders
331
Holders Change
+331
Holders Change %
–
% of All Funds
10.8%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.16%
New
331
Increased
–
Reduced
–
Closed
–
Calls
$100M
Puts
$30.6M
Net Calls
+$69.5M
Net Calls Change
+$69.5M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
176
McKinley Capital Management
Alaska
$793K +$853K +16,761 New
Cambridge Investment Research Advisors
177
Cambridge Investment Research Advisors
Iowa
$792K +$852K +16,734 New
SIM
178
Sentry Investment Management
Wisconsin
$780K +$840K +16,500 New
PA
179
Profund Advisors
Maryland
$771K +$830K +16,309 New
DC
180
Deere & Company
Illinois
$764K +$823K +16,157 New
TCM
181
Texan Capital Management
Texas
$759K +$818K +16,055 New
JFGIW
182
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$742K +$798K +15,677 New
TCOT
183
Trust Company of Toledo
Ohio
$738K +$795K +15,618 New
BO
184
BRR OpCo
Ohio
$719K +$775K +15,210 New
Macquarie Group
185
Macquarie Group
Australia
$699K +$752K +14,768 New
IAM
186
Impax Asset Management
New Hampshire
$643K +$693K +13,600 New
GCT
187
Galaxy Capital Trading
British Virgin Islands
$629K +$677K +13,300 New
ANI
188
American National Insurance
Texas
$623K +$671K +13,175 New
RFC
189
Regions Financial Corp
Alabama
$620K +$668K +13,113 New
NCCM
190
Nine Chapters Capital Management
New Jersey
$582K +$626K +12,300 New
CB
191
Commerce Bank
Missouri
$570K +$613K +12,035 New
HK
192
Horizon Kinetics
New York
$568K +$611K +12,000 New
SCA
193
SAC Capital Advisors
Connecticut
$566K +$609K +11,966 New
Manulife (Manufacturers Life Insurance)
194
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$550K +$592K +11,630 New
ISL
195
Ingalls & Snyder LLC
New York
$550K +$593K +11,636 New
IB
196
Intrust Bank
Kansas
$547K +$588K +11,553 New
HDIM
197
Hanson & Doremus Investment Management
Vermont
$547K +$588K +11,555 New
BTNA
198
Bremer Trust National Association
Minnesota
$546K +$588K +11,548 New
JMPWA
199
JP Morgan Private Wealth Advisors
California
$546K +$588K +11,552 New
HIM
200
Hillsdale Investment Management
Ontario, Canada
$545K +$587K +11,520 New
6 7
8
9 10

AZN Hedge Fund Activity: Q2 2013 in Review

331 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q2 2013, worth a combined $5.84B.

Buyers outnumbered sellers: 331 funds opened new AZN positions and 0 closed out — a net gain of 331 holders — while 0 added to existing stakes and 0 trimmed.

  • 331 institutional investors held AstraZeneca (AZN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $5.84B of AstraZeneca stock for Q2 2013.
  • 331 funds opened new AstraZeneca positions in Q2 2013 and 0 closed out, a net change of +331 holders.

Based on aggregated 13F filings for Q2 2013.